search
Back to results

Efficacy of a Program for the Management of Depression in Pregnant Women in Primary Care in São Paulo, Brazil (PROGRAVIDA)

Primary Purpose

Depression

Status
Unknown status
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
PROGRAVIDA
Sponsored by
University of Sao Paulo General Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Depression focused on measuring depression, problem solving

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

Pregnant women attending antenatal care in selected primary care clinics with Family Health Programs, who score a PHQ-9>=5 just after the first antenatal consultation or around the 20th week of pregnancy.

Exclusion Criteria:

Moderate to high suicidal risk (assessed with a standardised protocol),

  • Ongoing psychiatric treatment,
  • Not able to understand Portuguese.

Sites / Locations

  • Faculdade de Medicina da Universidade de Sao PauloRecruiting
  • Faculdade de Medicina da Universidade de Sao PauloRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

PROGRAVIDA

Treatment as usual

Arm Description

All women in this arm receive a stepped-care program for depression based on psycho-education and problem solving techniques.

Primary health care professionals in charge of prenatal care are notified by the research team about all women with depression receiving pre-natal care and included in the trial. Primary health care professionals decide how to treat these women without any interference from the research team.

Outcomes

Primary Outcome Measures

Patient Health Questionnaire (PHQ-9)
PHQ-9 score=<4 will be considered success

Secondary Outcome Measures

PHQ-9
PHQ-9 score=<4 will be considered success
General Quality of life (EQ-5D)
The instrument contains 2 parts: a descriptive part that evaluates five domains (mobility, self care, usual activity, discomfort / pain and anxiety / depression). In this section a person assesses the current health on a scale 1-3 (none, moderate and severe). The respondent also makes self-evaluation through visual scale grading their health from 0 (worst possible) to 100 (best possible).

Full Information

First Posted
October 29, 2012
Last Updated
October 31, 2012
Sponsor
University of Sao Paulo General Hospital
Collaborators
Conselho Nacional de Desenvolvimento Científico e Tecnológico
search

1. Study Identification

Unique Protocol Identification Number
NCT01719289
Brief Title
Efficacy of a Program for the Management of Depression in Pregnant Women in Primary Care in São Paulo, Brazil
Acronym
PROGRAVIDA
Official Title
Cluster Randomised Controlled Trial of a Primary-care Based Intervention to Improve Depressive Symptoms of Pregnant Women in Sao Paulo, Brazil
Study Type
Interventional

2. Study Status

Record Verification Date
October 2012
Overall Recruitment Status
Unknown status
Study Start Date
March 2011 (undefined)
Primary Completion Date
November 2013 (Anticipated)
Study Completion Date
September 2014 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Sao Paulo General Hospital
Collaborators
Conselho Nacional de Desenvolvimento Científico e Tecnológico

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Background: depression during pregnancy is an important problem for public health. It has direct consequences for the affected woman, her children and family, and is a strong predictor of post-partum depression. In developing countries depression during pregnancy is highly common, and usually unrecognized and untreated. Aim: to evaluate the effectiveness and cost-effectiveness of an intervention delivered by nurse assistants in the management of pregnant women with depression in primary care clinics that adopt the Family Health Strategy in Sao Paulo, Brazil. Method: PROGRAVIDA is a cluster randomized controlled trial with pregnant women with depression attending pre-natal care in 12 Primary Care Units with Family Health Program, covering an area of 400,000 inhabitants in Sao Paulo, Brazil. The intervention follows a stepped-care approach and is delivered by health professionals working at the primary care unit responsible by the care of the women. All women from the intervention group receive a program based on psycho-education and problem solving techniques, delivered by a nurse assistant at the women's homes. The program comprises 8 sessions, 6 during pregnancy and 2 after delivery. Intensity of depressive symptoms is assessed using the PHQ-9, at the beginning of the sessions. Women with severe depression are referred to the family doctor and are assessed for the need of antidepressant medication. The control group receives routine care. The primary outcome is remission of depressive symptoms 4-months after the inclusion in the study. Secondary outcomes include remission of depressive symptoms at 6 months after delivery. Women are also assessed for socioeconomic and household characteristics, social support and obstetric complications. The effectiveness and cost-effectiveness of the intervention will be assessed with intention-to-treat analysis, using the clinical outcome and the assessment of quality of life (EQ-5D) four months after inclusion in the trial.
Detailed Description
Despite the high prevalence of depressive disorders in pregnancy and puerperium and the possible negative consequences of these frames for women, children and family, there are still very scarce evidence on the effectiveness of interventions of low cost and viable, that can be made available on the net of Primary Health Care in Brazil and other middle or low income countries. The main objective of this study is to evaluate the effectiveness of a depression management program, simple and low cost, delivered by nurse assistants, in reducing symptoms of depression in pregnant women treated in primary care clinics that adopt the Family Health Strategy (FHS) in São Paulo, compared to routine care. We will also assess the cost-effectiveness of this intervention. We are conducting a community cluster randomized trial with pregnant women with symptoms of depression, attending antenatal care in primary care clinics that adopt the FHS in São Paulo. Participating clinics (12) were randomly allocated to have their nurse assistants receiving training and supervision to perform a program for management of depression among pregnant women (experimental group) or to offer routine care (control group).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Depression
Keywords
depression, problem solving

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
600 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
PROGRAVIDA
Arm Type
Experimental
Arm Description
All women in this arm receive a stepped-care program for depression based on psycho-education and problem solving techniques.
Arm Title
Treatment as usual
Arm Type
No Intervention
Arm Description
Primary health care professionals in charge of prenatal care are notified by the research team about all women with depression receiving pre-natal care and included in the trial. Primary health care professionals decide how to treat these women without any interference from the research team.
Intervention Type
Behavioral
Intervention Name(s)
PROGRAVIDA
Intervention Description
Women in the intervention group receive a program based on psycho-education and problem solving techniques, delivered by a nurse assistant at the women's homes. The program comprises 8 sessions, 6 during pregnancy and 2 after delivery. Intensity of depressive symptoms is assessed using the PHQ-9, at the beginning of the sessions. Women with severe depression are referred to the family doctor and are assessed for the need of antidepressant medication.
Primary Outcome Measure Information:
Title
Patient Health Questionnaire (PHQ-9)
Description
PHQ-9 score=<4 will be considered success
Time Frame
4 months after inclusion in the study
Secondary Outcome Measure Information:
Title
PHQ-9
Description
PHQ-9 score=<4 will be considered success
Time Frame
6 months after delivery
Title
General Quality of life (EQ-5D)
Description
The instrument contains 2 parts: a descriptive part that evaluates five domains (mobility, self care, usual activity, discomfort / pain and anxiety / depression). In this section a person assesses the current health on a scale 1-3 (none, moderate and severe). The respondent also makes self-evaluation through visual scale grading their health from 0 (worst possible) to 100 (best possible).
Time Frame
4 months after inclusion and 6 months after delivery

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Pregnant women attending antenatal care in selected primary care clinics with Family Health Programs, who score a PHQ-9>=5 just after the first antenatal consultation or around the 20th week of pregnancy. Exclusion Criteria: Moderate to high suicidal risk (assessed with a standardised protocol), Ongoing psychiatric treatment, Not able to understand Portuguese.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Paulo R Menezes, PhD
Phone
+55 11 30617093
Email
progravida@usp.br
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Paulo R Menezes, PhD
Organizational Affiliation
University of Sao Paulo
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Marcia Scazufca, PhD
Organizational Affiliation
University of Sao Paulo
Official's Role
Study Director
Facility Information:
Facility Name
Faculdade de Medicina da Universidade de Sao Paulo
City
Sao Paulo
ZIP/Postal Code
01246-903
Country
Brazil
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Paulo R Menezes, PhD
Phone
551130617093
Email
pmenezes@usp.br
First Name & Middle Initial & Last Name & Degree
Paulo R Menezes, PhD
First Name & Middle Initial & Last Name & Degree
Marcia Scazufca, PhD
Facility Name
Faculdade de Medicina da Universidade de Sao Paulo
City
São Paulo
ZIP/Postal Code
01246-903
Country
Brazil
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Paulo R Menezes, PhD
Phone
551130617093
Email
pmenezes@usp.br
First Name & Middle Initial & Last Name & Degree
Paulo R Menezes, PhD
First Name & Middle Initial & Last Name & Degree
Marcia Scazufca, PhD

12. IPD Sharing Statement

Learn more about this trial

Efficacy of a Program for the Management of Depression in Pregnant Women in Primary Care in São Paulo, Brazil

We'll reach out to this number within 24 hrs